Home Tags HuCAL technology platform

Tag: HuCAL technology platform

Anetumab Ravtansine does not meet Primary Endpoint in Second-Line Mesothelioma

A Phase II clinical trial evaluating its anetumab ravtansine, also known as BAY 949343, as a monotherapy in patients with recurrent malignant pleural mesothelioma...

X